Peritonsillar Abscess
10
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Transoral Ultrasound Versus no Transoral Ultrasound in Diagnostic Workup of Peritonsillar Abscess
Complicated Infections in Otorhinolaryngology
Medical Versus Surgical Treatment for Peritonsillar Abscesses
Penicillin and Metronidazole in Treatment of Peritonsillar Abscess
Ultrasound-Guided Aspiration of PTA vs Conventional Landmark Technique - a RCT
Peritonsillar Abscess: Aspiration Versus Tonsillectomy a Chaud
Assessing the Necessity of Prescribing Antibiotics (Clavulin or Clindamycin Versus Placebo) Post-peritonsillar Abscess Drainage
Auricular Acupuncture for The Treatment of Post-Tonsillectomy Pain
The Effect of Adding Pain Relievers to Local Anesthesia Before Preforming Drainage in Peritonsillar Abscess